Clinical trial

PD-1 Inhibitor Concurrent With Chemotherapy as Neoadjuvant Therapy for TNBC

NCT04809779

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2021-03-01

PhasePHASE2

Study timeline

Study start (estimated)2021-03-01Date precision: month

Registry last updated2021-03-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Triple Negative Breast Cancerunresolved

Interventions

SintilimabDRUG

Sponsors & collaborators

First Affiliated Hospital, Sun Yat-Sen Universitylead sponsor

Mapped research locations

GuangzhouChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04809779 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.